BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5080344)

  • 1. Effect of retinoic acid in psoriasis. II. Long term study.
    Macdonald A; McMinn RM; Fry L
    Br J Dermatol; 1972 Sep; 87(3):256-60. PubMed ID: 5080344
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of retinoic acid in psoriasis.
    Fry L; Macdonald A; McMinn RM
    Br J Dermatol; 1970 Sep; 83(3):391-6. PubMed ID: 5479312
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical vitamin A acid in the treatment of psoriasis.
    Peck GL; Key DJ; Guss SB
    Arch Dermatol; 1973 Feb; 107(2):245-8. PubMed ID: 4568264
    [No Abstract]   [Full Text] [Related]  

  • 4. Retinoic acid for psoriasis.
    Armati RP
    Australas J Dermatol; 1972 Aug; 13(2):79-83. PubMed ID: 4566493
    [No Abstract]   [Full Text] [Related]  

  • 5. Retinoic acid in psoriasis: its value for topical therapy with and without corticosteroids. Clinical, histological nd electron microscopical studies on forty-four hospitalized patients with extensive psoriasis.
    Orfanos CE; Schmidt HW; Mahrle G; Gartmann H; Lever WF
    Br J Dermatol; 1973 Feb; 88(2):167-82. PubMed ID: 4706460
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of vitamin A acid (VAA) on psoriasis. Topical combined therapy using corticoids. Two new VAA preparations for oral administration].
    Orfanos CE; Schmidt HW; Mahrle G; Runne U
    Arch Dermatol Forsch; 1972; 244():424-6. PubMed ID: 4648740
    [No Abstract]   [Full Text] [Related]  

  • 7. [Oral therapy of psoriasis using two vitamin A acid-derivatives (author's transl)].
    Runne U; Orfanos CE; Gartmann H
    Arch Dermatol Forsch; 1973 Aug; 247(2):171-80. PubMed ID: 4748765
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical treatment of psoriasis with triethylenethiophosphoramide (Thio-Tepa).
    Heydenreich G
    Br J Dermatol; 1971 Aug; 85(2):182-5. PubMed ID: 4998964
    [No Abstract]   [Full Text] [Related]  

  • 9. Zinc therapy and distribution in psoriasis.
    Voorhees JJ; Chakrabarti SG; Botero F; Miedler L; Harrell ER
    Arch Dermatol; 1969 Dec; 100(6):669-73. PubMed ID: 4903875
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors affecting the clearance of psoriasis with dithranol (anthralin).
    Comaish S; Smith J; Seville RH
    Br J Dermatol; 1971 Mar; 84(3):282-9. PubMed ID: 5572679
    [No Abstract]   [Full Text] [Related]  

  • 11. [Animal experiment studies on the effect of various ointment bases-ointments on the epidermis. 2. Studies on the effect of vaselinum flavum and various batches of cera liquida on the epidermis width and mitosis].
    Wollmann C; Meyer FU; Schwenke W
    Dtsch Gesundheitsw; 1972 Aug; 27(33):1571-5. PubMed ID: 5079016
    [No Abstract]   [Full Text] [Related]  

  • 12. Histological variations in lesions of psoriasis.
    Cox AJ; Watson W
    Arch Dermatol; 1972 Oct; 106(4):503-6. PubMed ID: 4116898
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vitamin A acid in hyperkeratoses, epithelial tumors and acne].
    Schumacher A; Stüttgen G
    Dtsch Med Wochenschr; 1971 Oct; 96(40):1547-51. PubMed ID: 4255258
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of bufexamac (Droxaryl) ointment and of its excipient on psoriasis cases: double-blind test.
    Van der Meersch J
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):904-8. PubMed ID: 4214665
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical hydroxyurea and psoriasis.
    Zackheim HS; Karasek MA; Cox AJ
    J Invest Dermatol; 1972 Jan; 58(1):24-7. PubMed ID: 4550492
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psoriasis and carcinoma of the skin].
    Wojnerowicz C
    Patol Pol; 1972; 23(2):273-8. PubMed ID: 5034483
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical and pathophysiological rationale for amethopterin in psoriasis.
    Weinstein GD
    Ann N Y Acad Sci; 1971 Nov; 186():452-66. PubMed ID: 5289429
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations of cell surfaces as a pathogenetic factor in psoriasis. Possible loss of contact inhibition of growth.
    Orfanos CE; Schaumburg-Lever G; Mahrle G; Lever WF
    Arch Dermatol; 1973 Jan; 107(1):38-46. PubMed ID: 4566189
    [No Abstract]   [Full Text] [Related]  

  • 19. [The oral administration of vitamin-A-acid in leukoplakias, hyperkeratoses and squamous cell carcinomas: results and tolerance].
    Ryssel HJ; Brunner KW; Bollag W
    Schweiz Med Wochenschr; 1971 Jul; 101(28):1027-30. PubMed ID: 5141778
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathology and histochemistry of psoriasis. II. Dynamics of lesions during treatment.
    Gordon M; Johnson WC; Burgoon CF
    Arch Pathol; 1967 Nov; 84(5):443-50. PubMed ID: 6054609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.